Psoriasis is a chronic inflammatory skin disorder, and current treatments include topical
therapies, phototherapy, systemic immune modulators, and biologics, aiming to alleviate …

A growing number of patients with Crohn's disease and ulcerative colitis have disease that is
refractory to multiple advanced therapies, have undergone multiple surgeries and require …

Background Tapinarof cream is a topical aryl hydrocarbon receptor–modulating agent under
investigation for the treatment of psoriasis. Tapinarof modulates the expression of interleukin …

Importance Once-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor,
demonstrated efficacy and was well tolerated in a phase 2b trial of patients with psoriasis …

Background Tapinarof cream 1% once daily, an aryl hydrocarbon receptor-modulating
agent, was significantly more efficacious than vehicle and well tolerated in two 12-week …

A new drug delivery system using an asymmetric polyethersulfone (PES) membrane
modified by SBA-15 and glutamine-modified SBA-15 (SBA-Q) was prepared in this study by …

Background: Psoriasis is a chronic and immune-mediated inflammatory skin disease. Many
studies have shown that curcumin (CUR) has strong anti-inflammatory effects and can …

Psoriasis (PSO) is a chronic autoimmune skin condition characterized by the rapid and
excessive growth of skin cells, which leads to the formation of thick, red, and scaly patches …

Background: Previous research has indicated a potential correlation between hidradenitis
suppurativa (HS) and psoriasis (PSO), two chronic inflammatory dermatological diseases …

Psoriasis is a long-lasting, immune-related inflammatory skin disease that affects 2–3% of
the global population. It is distinguished by erythematous, silvery, and scaly patches …